EP Patent

EP1131077B2 — Bicarbonate-based solution in two parts for peritoneal dialysis or as a substitution solution in continuous renal replacement therapy

Assigned to Baxter International Inc · Expires 2017-11-15 · 9y expired

What this patent protects

Patent listed against Triferic.

Drugs covered by this patent

Patent Metadata

Patent number
EP1131077B2
Jurisdiction
EP
Classification
—
Expires
2017-11-15
Drug substance claim
No
Drug product claim
No
Assignee
Baxter International Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.